P J Pickhardt1, M J Siegel. 1. Mallinckrodt Institute of Radiology, Washington University School of Medicine, St Louis, MO 63110, USA.
Abstract
PURPOSE: To study the appearance and distribution of posttransplantation lymphoproliferative disorder (PTLD) at abdominal computed tomography (CT). MATERIALS AND METHODS: The authors retrospectively analyzed pretreatment abdominal CT scans in 51 patients (mean age, 36 years) with PTLD after solid organ transplantation. All diagnoses were proved at either abdominal (n = 26) or extraabdominal (n = 25) pathologic examination. Presence or absence of abdominal involvement, appearance and distribution of disease, and association with abdominal symptoms were all analyzed. RESULTS: CT scans were abnormal in 36 of the 51 patients (71%). Fifteen patients (29%) had no CT, clinical, or pathologic evidence of abdominal involvement. Of the 36 patients with abdominal PTLD at CT, 22% had lymph node enlargement, 28% splenic involvement, and 81% extranodal or extrasplenic involvement. Extranodal abdominal sites included liver (53%), small bowel (25%), kidney (17%), mesentery (14%), adrenal gland (8%), abdominal wall (8%), colon (6%), stomach (3%), and gallbladder (3%). Frequency of abdominal involvement was greater for heart and liver transplant recipients (94%) than for lung and kidney transplant recipients (58%) (P < .01). Seventeen of 36 patients (47%) with abdominal PTLD had no evidence of extraabdominal disease. CONCLUSION: Extranodal involvement is more common than splenic or nodal involvement in patients with abdominal PTLD. The presence of such findings in a patient after transplantation strongly suggests the diagnosis of PTLD and warrants aggressive evaluation.
PURPOSE: To study the appearance and distribution of posttransplantation lymphoproliferative disorder (PTLD) at abdominal computed tomography (CT). MATERIALS AND METHODS: The authors retrospectively analyzed pretreatment abdominal CT scans in 51 patients (mean age, 36 years) with PTLD after solid organ transplantation. All diagnoses were proved at either abdominal (n = 26) or extraabdominal (n = 25) pathologic examination. Presence or absence of abdominal involvement, appearance and distribution of disease, and association with abdominal symptoms were all analyzed. RESULTS: CT scans were abnormal in 36 of the 51 patients (71%). Fifteen patients (29%) had no CT, clinical, or pathologic evidence of abdominal involvement. Of the 36 patients with abdominal PTLD at CT, 22% had lymph node enlargement, 28% splenic involvement, and 81% extranodal or extrasplenic involvement. Extranodal abdominal sites included liver (53%), small bowel (25%), kidney (17%), mesentery (14%), adrenal gland (8%), abdominal wall (8%), colon (6%), stomach (3%), and gallbladder (3%). Frequency of abdominal involvement was greater for heart and liver transplant recipients (94%) than for lung and kidney transplant recipients (58%) (P < .01). Seventeen of 36 patients (47%) with abdominal PTLD had no evidence of extraabdominal disease. CONCLUSION: Extranodal involvement is more common than splenic or nodal involvement in patients with abdominal PTLD. The presence of such findings in a patient after transplantation strongly suggests the diagnosis of PTLD and warrants aggressive evaluation.
Authors: David H Ballard; Parisa Mazaheri; Daniel C Oppenheimer; Meghan G Lubner; Christine O Menias; Perry J Pickhardt; William D Middleton; Vincent M Mellnick Journal: Radiographics Date: 2020-04-24 Impact factor: 5.333
Authors: Ralf Trappe; Heiner Zimmermann; Susanne Fink; Petra Reinke; Martin Dreyling; Andreas Pascher; Hans Lehmkuhl; Barbara Gärtner; Ioannis Anagnostopoulos; Hanno Riess Journal: Haematologica Date: 2011-07 Impact factor: 9.941